Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ostermann

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 28, 2007
[Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial]C T Rieger, M Dittmer, H Ostermann
Der Internist|May 1, 2009
[Fever of unknown origin in malignancies]C T Rieger, L Peterson, H Ostermann
Der Internist|October 13, 2010
[Therapy-refractory thrombocytopenia in a 28-year-old patient]D Sauter, H Ostermann, K Selleng, et al.
Thrombosis and Haemostasis|June 1, 1996
Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsisR M Mesters, N Flörke, H Ostermann, et al.
Intensive Care Medicine|May 1, 1997
Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shockM G Kiehl, H Ostermann, J Meyer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2007
Pulmonary MRI--a new approach for the evaluation of febrile neutropenic patients with malignanciesC Rieger, P Herzog, R Eibel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 11, 2007
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemiaC Rieger, S Geiger, T Herold, et al.
Anti-Cancer Drugs|April 2, 2004
Incidence and severity of ifosfamide-induced encephalopathyC Rieger, M Fiegl, J Tischer, et al.
Der Anaesthesist|February 4, 2009
[Severe sepsis and disseminated intravascular coagulation. Supplementation with antithrombin]M Angstwurm, J Hoffmann, H Ostermann, et al.
Chest|November 21, 1997
Inflammatory mediators in BAL fluid as markers of evolving pneumonia in leukocytopenic patientsM G Kiehl, H Ostermann, M Thomas, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Deutsche Medizinische Wochenschrift (1946)|September 28, 2007
[Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial]C T Rieger, M Dittmer, H Ostermann
Der Internist|May 1, 2009
[Fever of unknown origin in malignancies]C T Rieger, L Peterson, H Ostermann
Der Internist|October 13, 2010
[Therapy-refractory thrombocytopenia in a 28-year-old patient]D Sauter, H Ostermann, K Selleng, et al.
Thrombosis and Haemostasis|June 1, 1996
Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsisR M Mesters, N Flörke, H Ostermann, et al.
Intensive Care Medicine|May 1, 1997
Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shockM G Kiehl, H Ostermann, J Meyer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2007
Pulmonary MRI--a new approach for the evaluation of febrile neutropenic patients with malignanciesC Rieger, P Herzog, R Eibel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 11, 2007
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemiaC Rieger, S Geiger, T Herold, et al.
Anti-Cancer Drugs|April 2, 2004
Incidence and severity of ifosfamide-induced encephalopathyC Rieger, M Fiegl, J Tischer, et al.
Der Anaesthesist|February 4, 2009
[Severe sepsis and disseminated intravascular coagulation. Supplementation with antithrombin]M Angstwurm, J Hoffmann, H Ostermann, et al.
Chest|November 21, 1997
Inflammatory mediators in BAL fluid as markers of evolving pneumonia in leukocytopenic patientsM G Kiehl, H Ostermann, M Thomas, et al.
Pageof 7